O21 HCV reinfection and injecting risk behaviour following elbasvir/grazoprevir treatment in patients on opioid agonist therapy: Co-STAR three year follow-up study

Saved in:

Bibliographic Details
Main Authors:	G. Dore (Author), J. Grebely (Author), F. Altice (Author), A.H. Litwin (Author), O. Dalgard (Author), E.J. Gane (Author), O. Shibolet (Author), A. Luetkemeyer (Author), R. Nahass (Author), C.Y. Peng (Author), B. Conway (Author), D.M. Iser (Author), H.C. Huang (Author), I.N. Gendrano (Author), M. Kelly (Author), P. Hwang (Author), M. Robertson (Author), J. Wahl (Author), E. Barr (Author), H.L. Platt (Author)
Format:	Book
Published:	Elsevier, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

P64 Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir
by: N. Reau, et al.
Published: (2017)

Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence
by: Morikawa K, et al.
Published: (2018)

A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants
by: Li H, et al.
Published: (2020)

Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review
by: Jinyu Liu, et al.
Published: (2022)

Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy
by: Hézode C, et al.
Published: (2019)

Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam
by: Chizoba Nwankwo, et al.
Published: (2019)

Spotlight on grazoprevir—elbasvir once-daily combination and its potential in the treatment of hepatitis C
by: Suraweera D, et al.
Published: (2016)

Development and Validation of new RP-HPLC Method for the Simultaneous Estimation of Elbasvir and Grazoprevir in Combined Pharmaceutical Dosage Form
by: P Seetharamaiah, et al.
Published: (2023)

Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
by: Jinyu Liu, et al.
Published: (2021)

A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
by: Hsuan-Yu Hung, et al.
Published: (2021)

Reinfection of farm dogs following praziquantel treatment in an endemic region of cystic echinococcosis in southeastern Iran.
by: Mehdi Borhani, et al.
Published: (2024)

Reinfection of dogs with fish-borne zoonotic trematodes in northern Vietnam following a single treatment with praziquantel.
by: Sofie Nissen, et al.
Published: (2014)

Hepatitis C reinfection in former and active injecting drug users in Belgium
by: Dana Busschots, et al.
Published: (2021)

The Impact of Clinical Pharmacist Tele-follow-up on Diabetic Patient's Readmission Due to Reinfection of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Iraqi Patients
by: kawthar faris, et al.
Published: (2024)

Should we concern about reinfection in COVID-19?
by: Alfonso J. Rodriguez-Morales
Published: (2022)

COVID-19: Is Reinfection a Threat or Not?
by: Julián Felipe PORRAS VILLAMIL, et al.
Published: (2020)

The Recurrence of Infection: Recrudescence Versus Reinfection
by: Jong Kyu Park
Published: (2023)

Likelihood of COVID-19 reinfection in an urban community cohort in Massachusetts
by: Sharon M. Casey, et al.
Published: (2022)

Reinfection, immunity and prevention of transmission of COVID-19
by: Humberto Guanche Garcell, et al.
Published: (2021)

Comparative genomics and full-length Tprk profiling of Treponema pallidum subsp. pallidum reinfection.
by: Amin Addetia, et al.
Published: (2020)

Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.
by: Mariane M A Stefani, et al.
Published: (2017)

O9 Progress towards elimination: rapid uptake of HCV treatment among people who inject drugs following broad access to DAA therapies
by: J. Iversen, et al.
Published: (2017)

Risk of developing psychiatric disease among adult patients with skin disease: A 9‐year national register follow‐up study in Norway
by: Flora Balieva, et al.
Published: (2023)

Reinfection And Bilateral Infection : Two Rare Manifestations Of Sporotrichosis
by: Maiti P. K, et al.
Published: (1999)

Reinfection in patients with COVID-19: a systematic review
by: Xiangying Ren, et al.
Published: (2022)

Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis.
by: Tie-Wu Jia, et al.
Published: (2012)

[Translated article] Annular Plaques on the Foreskin and Scrotum in the Context of Secondary Reinfection Syphilis
by: P. Ruiz-Mesa, et al.
Published: (2023)

The Resistance of Chagasic Wistar Rat Offspring to Reinfections by Trypanosoma cruzi
by: Nora Mogollón, et al.
Published: (2012)

COVID-19 reinfections in Mexico City: implications for public health
by: Guillermo de Anda-Jáuregui, et al.
Published: (2024)

SARS-CoV-2 reinfection and implications for vaccine development
by: Firzan Nainu, et al.
Published: (2020)

COVID-19 reinfection: the role of natural immunity, vaccines, and variants
by: Bao Y. Sciscent, et al.
Published: (2021)

Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study
by: Trude Haugland, et al.
Published: (2013)

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
by: J. Hoes, et al.
Published: (2022)

Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures
by: Sato Y, et al.
Published: (2012)

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia
by: C.-M. Baxter, et al.
Published: (2018)

Following Tradition
by: Bronner, Simon J.
Published: (1998)

Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection
by: Huiling Zheng, et al.
Published: (2024)

Influenza A (H1N1) 2009 reinfection in Thailand
by: Satariya Trakulsrichai, et al.
Published: (2012)

Factors associated with reinfection of syphilis in reference centers for sexually transmitted infections
by: Valéria Correa de Almeida, et al.

Possible Cases of SARS-CoV-2 Reinfection In Pekanbaru, Indonesia
by: Rahmat Azhari Kemal, et al.
Published: (2022)